The Scientist

» industry and developmental biology

Most Recent

image: Abbott Acquires Diagnostics Firm

Abbott Acquires Diagnostics Firm

By | February 2, 2016

In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Bayer Enters CRISPR Field

Bayer Enters CRISPR Field

By | December 22, 2015

The pharmaceutical company will spend $335 million on a new venture with biotech startup CRISPR Therapeutics.

0 Comments

image: Earnings for New PhDs

Earnings for New PhDs

By | December 14, 2015

A project examining the relationship between research funding and economic productivity offers insights into where new graduates work and what they earn.

0 Comments

image: The Cyclopes of Idaho, 1950s

The Cyclopes of Idaho, 1950s

By | December 1, 2015

A rash of deformed lambs eventually led to the creation of a cancer-fighting agent.

0 Comments

image: Blood Cell Development Reimagined

Blood Cell Development Reimagined

By | November 9, 2015

A new study is rewriting 50 years of biological dogma by suggesting that mature blood cells develop much more rapidly from stem cells than previously thought.

0 Comments

image: Adding Padding

Adding Padding

By | November 1, 2015

Adipogenesis in mice has alternating genetic requirements throughout the animals’ lives.

0 Comments

image: 2015 Life Sciences Salary Survey

2015 Life Sciences Salary Survey

By and | November 1, 2015

This year’s survey highlights dramatic regional, sector, and gender variations.

13 Comments

image: Stem Cell Therapy In Utero

Stem Cell Therapy In Utero

By | October 13, 2015

An upcoming clinical trial aims to correct for a disease of fragile bones in affected babies before they are born.

0 Comments

image: Teva Buys Mexican Pharma Firm

Teva Buys Mexican Pharma Firm

By | October 5, 2015

The Israeli drugmaker is purchasing the pharmaceutical company Rimsa for $2.3 billion.

0 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Athletes’ Microbiomes Differ from Nonathletes
  3. Mutation Linked to Longer Life Span in Men
  4. Gut Feeling
    Daily News Gut Feeling

    Sensory cells of the mouse intestine let the brain know if certain compounds are present by speaking directly to gut neurons via serotonin.

AAAS